Skip to main content

Table 1 Characteristics of the included studies

From: Effect of qigong on pain and disability in patients with chronic non-specific low back pain: a systematic review and meta-analysis of randomized controlled trials

Author

Region/year

Sample size (IG/CG)

Male

Age (year)

Course of disease

Prescription

Time

Duration

Frequency

Outcomes

Intervention

Liu, et al

China/2022

25/25

IG: 8

IG: 44.44 ± 12.48

IG: 19.44 ± 7.53 months

IG: Yijinjing

IG: 30 min

IG: 12 week

IG: 3/week

VAS, SF-36, LROM, ODI, HAMA, HAMD, IL-6, TNF-α, 5-HT

   

CG: 9

CG: 47.96 ± 17.32

CG: 22.32 ± 11.20 months

CG: Health education

CG: l h

CG: 12 week

CG: 1/week

 

Qi, et al

China/2017

25/25

IG: 12

IG: 49.53 ± 10.87

IG: 4.53 ± 2.08 months

IG: Baduanjin

IG: NI

IG: 2 months

IG: 5/week

VAS, JOA

   

CG: 13

CG: 48.27 ± 11.35

CG: 4.36 ± 1.44 months

CG: Suspension exercise therapy

CG: 45 min

CG: 2 months

CG: 5/week

 

Ning, et al

China/2014

26/26

IG: 12

IG: 40.73 ± 11.52

IG: NI

IG: Wuqinxi

IG: 30 min

IG: 3 months

IG: 3/week

VAS, ODI, LROM, RR

   

CG: 11

CG: 42.13 ± 11.18

CG: NI

CG: Core strength training

CG: NI

CG: 3 months

CG: 3/week

 

Ye, et al

China/2018

25/28

IG: 10

IG: 40.31 ± 7.59

IG: 6.95 ± 3.50 months

IG: Liuzijue + Usual care

IG: 30 min

IG: 4 week

IG: 5/week

VAS, ODI

   

CG: 15

CG: 38.98 ± 8.27

CG: 7.07 ± 2.98 months

CG: Usual care

CG: 30 min

CG: 4 week

CG: 5/week

 

Gao, et al

China/2016

30/30

IG: 17

IG: 35.68 ± 12.56

IG: 16.33 ± 6.89 months

IG:Baduanjin + Routine Rehabilitation

IG: 30 min

IG: 8 week

IG: 6/week

VAS, HADS, ODI, PSEQ

   

CG: 21

CG: 36.45 ± 12.38

CG: 17.10 ± 6.52 months

CG: Routine Rehabilitation

CG: 30 min

CG: 8 week

CG: 6/week

 

Phattharasupharerk, et al

Thailand/2018

36/36

IG: 12

IG: 35.7 ± 3.6

IG: NI

IG:GuanYinZiZaiGong

IG: 1 h

IG: 6 week

IG: 1/week

VAS, RMDQ, LROM, CSPI, HR, RR, ST-5

   

CG: 14

CG: 34.8 ± 4.3

 

CG: Waiting List

    

Yang, et al

China/2022

29/27

IG: 14

IG: 31.24 ± 3.82

IG: 13.31 ± 2.54 months

IG: Baduanjin

IG: 30 min

IG: 4 week

IG: 5/week

NPRS, ODI, SEMG

   

CG: 13

CG: 31.78 ± 2.59

CG: 12.15 ± 2.14 months

CG: walking

CG: 30 min

CG: 4 week

CG: 5/week

 

Su, et al

China/2019

32/32

IG: 8

IG: 58.19 ± 4.70

IG: 4.63 ± 1.21 years

IG: Baduanjin

IG: 45 min

IG: 12 week

IG: 4/week

VAS, ODI

   

CG: 11

CG: 58.75 ± 5.21

CG: 4.78 ± 1.60 years

CG: Health education

CG: NI

CG: 12 week

CG: 4/week

 

Liu, et al

China/2020

47/53

IG: 9

IG: 58.34 ± 4.89

IG: 4.02 ± 1.01 years

IG: Baduanjin

IG: ≥ 30 min

IG: 12 week

IG: 5/week

VAS, ODI

   

CG: 14

CG: 60.92 ± 7.52

CG: 3.77 ± 1.33 years

CG: Medical treatment + Aerobic exercise

CG: NI

CG: 12 week

CG: 5/week

 

He, et al

China/2019

60/60

IG: 38

IG: 41.70 ± 6.58

IG: 16.47 ± 2.21 months

IG: Baduanjin

IG: NI

IG: 12 week

IG: 5/week

VAS, ODI, FFD, JOA

   

CG: 42

CG: 42.52 ± 6.61

CG: 16.82 ± 2.26 months

CG: Routine Rehabilitation

CG: NI

CG: 12 week

CG: 5/week

 

Fang, et al

China/2015

32/31

IG: NI

IG:52.91 + 15.80

IG: 13.17 + 9.21 years

IG: Wuqinxi

IG: 30–60 min

IG: 6 months

IG: 3–4/week

VAS, IEMG

   

CG: NI

CG:53.88 + 14.17

CG: 12.36 ± 10.75 years

CG: McKenzie Gymnastics

CG: 30–60 min

CG: 6 months

CG: 3–4/week

 

Su, et al

China/2020

37/39

IG: 8

IG: 68.86 ± 4.63

IG: 4.57 ± 1.07 years

IG: Baduanjin

IG: 45 min

IG: 12 week

IG: 4/week

VAS, ODI

   

CG: 11

CG: 70.74 ± 6.96

CG: 5.10 ± 1.74 years

CG: Health education

CG: NI

CG: 12 week

CG: 4/week

 

Zhang, et al

China/2019

37/40

IG: NI

IG: NI

IG: NI

IG: Baduanjin

IG: NI

IG: 10 week

IG: 5/week

LROM, VAS

   

CG: NI

CG: NI

CG: NI

CG: Five point support functional exercise

CG: NI

CG: 10 week

CG: 5/week

 

Zhang,

China/2023

20/20

IG: 12

IG: 42.8 ± 2.7

IG: NI

IG: Breathing exercises and core exercises

IG: 30 min

IG: 4 week

IG: 5/week

VAS, ODI

   

CG: 11

CG: 43.5 ± 3.8

CG: NI

CG: Usual care

CG: 30 min

CG: 4 week

CG: 5/week

 

Blodt, et al

Germany/2015

64/63

IG: 6

IG: 45.7 ± 10

IG: 2.7 ± 1.4 years

IG: Neiyanggong

IG: 90 min

IG: 12 weeks

IG: 1/week

VAS, RMDQ, SF-36

   

CG: 19

CG: 47.7 ± 10.8

CG: 3.2 ± 1.5 years

CG: Exercise therapy

CG: 60 min

CG: 12 weeks

CG: 1/week

 

Teut, et al

Germany/2016

58/57

IG: 8

IG: 72.4 ± 5.7

IG: 18.1 ± 13.2 years

IG: Neiyanggong

IG: 90 min

IG: 3 months

IG: 1/week

FRI, VAS, SF-36, GDS, BF

   

CG: 5

CG: 72.6 ± 6.0

CG: 19.6 ± 16.3 years

CG: Waiting list

    
  1. VAS, visual analog scale; ODI, Oswestry Disability Index; JOA, Japanese Orthopedic Association; FFD, finger-floor distance; IG, intervention group; CG, control group; NI, no information; SF-36, short form 36; LROM, Range of motion of lumbar joint; RR, recurrence rate; ER, effective rate; SF-MPQ, McGill Pain Questionnaire Short-Form; IEMG, integrated electromyography; HAMA, Hamilton Anxiety Scale; HAMD, Hamilton Depression Scale; IL-6, interleukin-6; TNF-α, tumor necrosis factor; 5-HT, 5-hydroxytryptamine; PSEQ, Pain Self-efficacy Questionnaire; RMDQ, Roland-Morris Disability Questionnaire; CSPI, Core Stability Performance Index; HR, heart rate; RR, respiratory rate; ST-5, Srithanya Stress Scale; SEMG, surface electromyography; NPRS, Numeric Pain Rating Scale; GDS, Geriatric Depression Scale; FRI, Functional Rating Index; BF, back function